Status:
COMPLETED
Integrated Behavioral Intervention for Cigarette Smoking and Binge Drinking in Young Adults
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
James and Esther King Biomedical Research Program
Conditions:
for Cigarette Smoking and Binge Drinking Cessation
Eligibility:
All Genders
18-30 years
Phase:
NA
Brief Summary
RATIONALE: Nicotine patches and behavioral therapy may help reduce cigarette smoking and binge drinking in young adults. PURPOSE: This randomized clinical trial studies nicotine patches with or withou...
Detailed Description
OBJECTIVES: I. To evaluate the efficacy of Integrated Intervention that targets both cigarette smoking and binge drinking on the cigarette smoking behavior of young adult smokers at 6-month follow-up....
Eligibility Criteria
Inclusion
- Smoked an average of \>= 10 or more cigarettes per day during the past 6 months - Binge drank on an average of \>= 2 occasions per month during the past 3 months - Able to participate fully in all aspects of the intervention and keep all scheduled appointments - Willing to participate in 6 months of follow-up - Willing to stop smoking and use nicotine patch therapy - Willing to refrain from participating in additional smoking interventions for the duration of the study - Provide written informed consent
Exclusion
- Current (past 90 days) alcohol dependence as assessed by the Structured Clinical Interview for DSM-IV Axis I Disorders, Alcohol Dependence Module - Current (past 12 months) non-nicotine or alcohol drug dependence as assessed by a Drug Abuse Screening Test-20 score of \>= 6 - Current elevation of depressive symptoms (past 2 weeks) that would be indicative of clinical depression as assessed by a Beck Depression Inventory-II score of \>= 20 - Current use (past 30 days) of nicotine containing medication or frequent use (\> 10 occasions per month) of tobacco products other than cigarettes - Current use (past 30 days) of any other smoking cessation treatment involving behavioral or pharmacological interventions - Any medical condition that would preclude use of the nicotine patch including current unstable angina, recent history (past 30 days) of myocardial infarction or stroke, history of severe skin allergies, or evidence of severe chronic dermatosis - Currently pregnant or breast feeding, or likely to become pregnant during the nicotine patch phase
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2013
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT01184261
Start Date
August 1 2010
End Date
February 1 2013
Last Update
March 26 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Jacksonville, Florida, United States